TG101209
TG101209 is a potent and selective JAK2 inhibitor, demonstrating an IC50 of 6 nM. It is a valuable research tool for studying JAK-STAT signaling in myeloproliferative disease models, both in cellular assays and in vivo studies.
Product Specifications
CAS Number
936091-14-4
Product Name Alternative
Autophagy, Apoptosis, CD135, Cluster of differentiation antigen 135, cRET, JAK, Janus kinase, JAK3, JAK2, inhibit, Inhibitor, FLT3, Fms like tyrosine kinase 3, RET, TG101209, TG-101209, TG 101209
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Purity
98.81% (May vary between batches)
Solubility
Ethanol:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.47 mM) ; DMSO:94 mg/mL (184.43 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
CN1CCN (CC1) c1ccc (Nc2ncc (C) c (Nc3cccc (c3) S (=O) (=O) NC (C) (C) C) n2) cc1
Molecular Formula
C26H35N7O2S
Molecular Weight
509.67
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog